Advances in Organ Transplantation Will Boost the Global Transplant Diagnostics Market Growth | Industry Analysis Report 2025

The global transplant diagnostics market size is expected to grow at a CAGR of over 6% during the forecast period 2019-2025.

The global transplant diagnostics market is growing at a steady rate, which is expected to continue during the forecast period. The high demand for molecular diagnostic tests and the availability of technologically advanced devices with favorable patient demographics are mainly contributing to the high demand for transplant diagnostics devices. Ongoing technological advancements and innovations witnessed in the development of new genomic, transcriptomic, and proteomic biomarkers, especially in the molecular segment, can provide personalized management for transplantation and can detect rejection episodes and infections early, thereby improving the patient outcomes and success rate.

The following factors are likely to contribute to the transplant diagnostics market growth during the forecast period:
o Growing Number of Transplantations & Prevalence of Chronic Diseases
o Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients
o Emergence of cfDNA in Transplant Diagnostics
o Increasing Focus on Identifying New Biomarkers for Minimizing Transplantation Rejection

The study considers the present scenario of the global transplant diagnostics market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines key market players and other prominent companies operating in the market.

Request for a free Sample report: https://www.arizton.com/market-reports/transplant-diagnostics-market

Transplant Diagnostics Market Segmentation

The growing number of solid organ and stem cell replacement, advances in organ transplantation, increase in funding and research grants, and improved public-private investments, and the shift from serological-based tests to gene-based HLA profiling are major factors contributing the growth of the transplant diagnostics market. The growing adoption of molecular-based techniques in transplantations with the wide availability of PCR and sequence-based products is contributing to the growth of the segment.

Advances in serology and cellular assays have broadened the scope of transplant immunology technologies. Non-molecular tests have also been contributing sizeable revenues to the global transplant diagnostics market. Their potential in antibody-based histocompatibility tests, especially for lymphocyte micro cytotoxicity testing, has been fueling the demand. Several vendors are offering non-molecular testing products, which is further contributing to the growth.

This research report includes detailed market segmentation by product, application, technology, transplantation type, end-user, and geography.

Market Segmentation by Product
o Instruments & Software
o Consumables & Test Kits

Market Segmentation by End-user
o Standards Reference Laboratories
o Hospitals and Transplant Centers
o Research and Academic Centers

Market Segmentation by Transplant Type
o Solid Organs
o Soft Tissues

Market Segmentation by Technology
o Molecular
o Non-molecular

Market Segmentation by Application
o Diagnostic
o Research

Transplant Diagnostics Market Insights by Geography

The presence of a large pool of the patient population with terminal diseases and the high acceptance of advanced and innovative molecular procedures for transplant diagnostics have collectively supported the growth. France, the UK, Spain, Germany, and Italy are the major revenue contributors to the Europe market. The availability of highly sophisticated healthcare infrastructure and high awareness of advanced transplant procedures are contributing to the growth during the forecast period.

Transplant Diagnostics Market Insights by Vendors

The global transplant diagnostics market is moderately competitive and characterized by the presence of a few players offering these products. It is consolidated with a few players accounting for around 75% of the overall market in 2019. The market is witnessing rapid technological advancements, especially in the molecular diagnostics segment. Moreover, key players are witnessing increased competition from various regional and local players globally.

Key Vendors
o Thermo Fisher Scientific
o Hoffmann-La Roche
o bioMérieux
o Bio-Rad Laboratories
o QIAGEN
o Immucor

Other Vendors
o BAG Diagnostics
o CareDx
o ELITechGroup
o Genome Diagnostics
o Illumina
o NanoString Technologies
o Omixon
o Transplant Genomics
o Wakunaga Pharmaceutical

Read More: Request for a free Sample report: https://www.arizton.com/market-reports/transplant-diagnostics-market

About Arizton Advisory & Intelligence
Arizton - Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including -Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-235-2040

This release was published on openPR.